63 related articles for article (PubMed ID: 9005695)
1. External Evaluation of a Gentamicin Infant Population Pharmacokinetic Model Using Data from a National Electronic Health Record Database.
Ge S; Beechinor RJ; Hornik CP; Standing JF; Zimmerman K; Cohen-Wolkowiez M; Laughon MM; Clark R; Gonzalez D
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914947
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin concentration and acute kidney injury in term neonates treated for neonatal sepsis with gentamicin and ampicillin-cloxacillin combination.
James ME; Naburi H; Mugusi S; Kunambi PP; Mwakyandile T; Mnkugwe RH; Khalfan MA; Moshi MJ; Minzi OM; Sasi P
Antimicrob Agents Chemother; 2024 May; ():e0149523. PubMed ID: 38747600
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of gentamicin: evaluation of five nomograms for initial dosing at Al-Amiri Hospital in Kuwait.
Al-Lanqawi Y; Capps P; Abdel-hamid M; Abulmalek K; Phillips D; Matar K; Sharma P; Thusu A
Med Princ Pract; 2007; 16(5):348-54. PubMed ID: 17709922
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
[TBL] [Abstract][Full Text] [Related]
5. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
[TBL] [Abstract][Full Text] [Related]
6. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
[TBL] [Abstract][Full Text] [Related]
8. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring and pharmacokinetic dose prediction methods.
Oellerich M
Wien Klin Wochenschr Suppl; 1992; 191():12-5. PubMed ID: 1509745
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.
Triggs E; Charles B
Clin Pharmacokinet; 1999 Oct; 37(4):331-41. PubMed ID: 10554048
[TBL] [Abstract][Full Text] [Related]
11. Aminoglycosides: assessing the potential for nephrotoxicity.
Wilson SE
Surg Gynecol Obstet; 1990; 171 Suppl():24-30. PubMed ID: 2244292
[TBL] [Abstract][Full Text] [Related]
12. [Nephrotoxicity of iodine contrast media].
Meyrier A
Ann Radiol (Paris); 1994; 37(4):286-95. PubMed ID: 8085753
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
